Company intelligence / Profile preview

Jiangsu Ambison Pharmaceutical

Taizhou, Jiangsu, China

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Jiangsu Ambison Pharmaceutical is a China-based pharmaceutical company focused on the development, manufacturing, and commercialization of high-quality generic and innovative small molecule drugs. The company specializes in therapeutic areas such as cardiovascular health, central nervous system disorders, and metabolic diseases. Ambison is known for its commitment to international quality standards, often seeking both Chinese NMPA and US FDA approvals for its manufacturing facilities and products. Their portfolio includes widely used treatments for hypertension and hyperlipidemia, as well as specialized psychiatric medications.

Therapeutic areas: CardiovascularPsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jiangsu Ambison Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Ambison Pharmaceutical.

Explore the full profile